2 Minute Medicine

Ultrasound-guided stellate ganglion block attenuates early postoperative visceral pain after laparoscopic hysterectomy: A prospective randomized controlled trial

Ultrasound-guided stellate ganglion block significantly reduces early postoperative visceral pain after laparoscopic ...

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized ...
ascopubs.org

Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial

Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results We conducted a prospective ...
MedPage Today

Sound Evidence to Treat Smaller, Recurrent Endometrial Cancers With Radiotherapy Alone

Few randomized studies exist examining the treatment regimens of recurrent cancers. GOG 238 is a prospective randomized trial evaluating the role of radiation therapy (RT) versus chemoradiation in the ...
Medical Dialogues

Stellate Ganglion Block Reduces Postoperative Pain and Opioid Use After Laparoscopic Hysterectomy: Study

Researchers have found in a new study that Ultrasound-guided stellate ganglion block significantly decreases early postoperative visceral pain following laparoscopic hysterectomy. The ...
ascopubs.org

Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial

Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma Between February 2008 and August 2020, 165 patients were randomly assigned 1:1 to receive ...
The American Journal of Managed Care

Assay Finds Patients Who Will Benefit From Adjuvant Chemotherapy in Early-Stage NSCLC

Biomarker testing identifies high-risk early-stage NSCLC patients for adjuvant chemotherapy, reducing recurrence risk by 78%. The AIM-HIGH study shows a 96% disease-free survival rate at 24 months ...
TCTMD

Prospective Randomized Trial Evaluating Clinical Outcomes of Angiography-Based Fractional Flow Reserve Guidance Versus Wire-Based Fractional Flow Reserve Guidance: The ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
MedPage Today

Randomized Comparison of MRI vs Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial

Richard T. Bryan, PhD, Wenyu Liu, PhD, Sarah J. Pirrie, MSc, Rashid Amir, FRCR, Jean Gallagher, Ana I. Hughes, MSc, Kieran P. Jefferson, FRCS, Allen Knight, MBA ...